RVNC Final Deadline Tomorrow: Rosen, Global Investor Counsel, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCNewsfile Corp • 02/07/22
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Revance Investors of a Lead Plaintiff Deadline of February 8, 2022PRNewsWire • 02/07/22
TUESDAY DEADLINE: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – RVNCBusiness Wire • 02/05/22
Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Revance Therapeutics, Inc. (RVNC) Investors of Filing Deadline in Class Action LawsuitBusiness Wire • 02/05/22
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Revance Therapeutics, Inc. (RVNC) That a Securities Fraud Class Action Lawsuit Has Been Filed On Their BehalfPRNewsWire • 02/04/22
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - RVNCPRNewsWire • 02/04/22
Deadline Tuesday Notice: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/04/22
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)Business Wire • 02/04/22
DEADLINE NEXT WEEK: Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RVNCNewsfile Corp • 02/04/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action - RVNCNewsfile Corp • 02/03/22
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • 02/03/22
Deadline Tuesday Alert: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/03/22
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Revance Therapeutics, Inc. (RVNC) InvestorsNewsfile Corp • 02/03/22
RVNC LAWSUIT ALERT: Levi & Korsinsky Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 02/02/22
Tuesday Deadline Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/02/22
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Revance Therapeutics, Inc.Newsfile Corp • 02/02/22
RVNC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 8, 2022 in the Class Action Filed on Behalf of Revance Therapeutics, Inc. Limited ShareholdersPRNewsWire • 02/01/22
7-Day Deadline Reminder: The Schall Law Firm Encourages Investors in Revance Therapeutics, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/01/22
RVNC Alert: Thornton Law Firm Reminds Revance Therapeutics Investors of Securities Class ActionNewsfile Corp • 02/01/22
RVNC Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC, a Nationally Recognized Firm, Reminds Revance Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 8, 2022Newsfile Corp • 01/31/22
SECURITIES CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds RVNC Investors of Upcoming Deadline and Urges Investors with Substantial Losses to Contact the FirmPRNewsWire • 01/30/22
(RVNC) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Revance Therapeutics Class Action LawsuitNewsfile Corp • 01/29/22
